Publications by authors named "Daniel Bexell"

Claim this Profile
R
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.
Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos, Javanshir Esfandyari, Aleksandra Adamska, Daniel Bexell

EMBO Mol Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.
Alexandra Seger, Dora Adamič, Erick Muciño Olmos, Johannes Nilsson, Sofia Granados-Aparici, Daniel Bexell

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.
Adriana Mañas, Alexandra Seger, Aleksandra Adamska, Kyriaki Smyrilli, Joachim T Siaw, Daniel Bexell

NPJ Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma.
Emma Lindell, Jing Guo, Miao Zhao, Natallia Rameika, Xi Lu, Daniel Bexell

Cell Death Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary unpredictability in cancer model systems.
Subhayan Chattopadhyay, Jenny Karlsson, Michele Ferro, Adriana Mañas, Ryu Kanzaki, Daniel Bexell

Sci Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.
Jenny Karlsson, Hiroaki Yasui, Adriana Mañas, Natalie Andersson, Karin Hansson, Daniel Bexell

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer associated CD169 macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells.
Frida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, Eva Källberg, Cajsa Andersen, Daniel Bexell

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy.
Anders Valind, Bronte Manouk Verhoeven, Jens Enoksson, Jenny Karlsson, Gustav Christensson, Daniel Bexell

Oncoimmunology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived models: Advanced tools for precision medicine in neuroblastoma.
Kristina Aaltonen, Katarzyna Radke, Aleksandra Adamska, Alexandra Seger, Adriana Mañas, Daniel Bexell

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.
Ani Grigoryan, Dimitra Zacharaki, Alexander Balhuizen, Christophe Rm Côme, Alejandro Garcia Garcia, Daniel Bexell

Sci Transl Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.
Adriana Mañas, Kristina Aaltonen, Natalie Andersson, Karin Hansson, Aleksandra Adamska, Daniel Bexell

Sci Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis.
Franziska Olm, Lena Panse, Josefina H Dykes, Daniel Bexell, Thomas Laurell

Stem Cell Res Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects of rigosertib in high-risk neuroblastoma.
Katarzyna Radke, Karin Hansson, Jonas Sjölund, Magdalena Wolska, Jenny Karlsson, Daniel Bexell

Transl Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma.
María Victoria Ruiz-Pérez, Lourdes Sainero-Alcolado, Ganna Oliynyk, Isabell Matuschek, Nicola Balboni, Daniel Bexell

iScience· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer.
Meliha Mehmeti-Ajradini, Caroline Bergenfelz, Anna-Maria Larsson, Robert Carlsson, Kristian Riesbeck, Daniel Bexell

Life Sci Alliance· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of -Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma.
Wondossen Sime, Mohamed Jemaà, Yasmin Abassi, Vito Alessandro Lasorsa, Julie Bonne Køhler, Daniel Bexell

Int J Mol Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma.
Karin Hansson, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Daniel Bexell

Sci Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells.
Frida Björk Gunnarsdóttir, Catharina Hagerling, Caroline Bergenfelz, Meliha Mehmeti, Eva Källberg, Daniel Bexell

Exp Cell Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.
Camilla U Persson, Kristoffer von Stedingk, Elina Fredlund, Daniel Bexell, Sven Påhlman

Exp Cell Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative discovery of treatments for high-risk neuroblastoma.
Elin Almstedt, Ramy Elgendy, Neda Hekmati, Emil Rosén, Caroline Wärn, Daniel Bexell

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Aparicio, Daniel Bexell

EMBO Mol Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
Liselot M Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Daniel Bexell

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Apiricio, Daniel Bexell

EMBO Mol Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered human mesenchymal stem cells for neuroblastoma therapeutics.
Valentina Nieddu, Roberta Piredda, Daniel Bexell, Jack Barton, John Anderson

Oncol Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional intratumour heterogeneity in neuroblastoma.
Kristoffer von Stedingk, David Gisselsson, Daniel Bexell

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis